Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance

Biological Psychiatry

Volumn 73, Issue 9, 2013, Pages 895-903

  Dubreucq, Sarah ^a,c   Durand, Audrey ^a,c   Matias, Isabelle ^a,c   Bénard, Giovanni ^a,c   Richard, Elodie ^a,c   Soria Gomez, Edgar ^a,c   Glangetas, Christelle ^b,c   Groc, Laurent ^b,c   Wadleigh, Aya ^a,c   Massa, Federico ^a,c   Bartsch, Dusan ^d   Marsicano, Giovanni ^a,c   Georges, Francois ^b,c   Chaouloff, Francis ^a,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

CB1 receptors; dopamine; GABA; physical exercise; ventral tegmental area; wheel running

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CONTROLLED STUDY; EXERCISE; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NERVE CELL; NEUROPHYSIOLOGY; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TASK PERFORMANCE; VENTRAL TEGMENTUM; WILD TYPE;

ANIMALS; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; PHYSICAL CONDITIONING, ANIMAL; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; VENTRAL TEGMENTAL AREA;

EID: 84876280658     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.10.025     Document Type: Article

References (65)

1. E.W. Martinsen, and W.P. Morgan Antidepressant effects of physical activity W.P. Morgan, Physical Activity & Mental Health 1997 Taylor & Francis Washington, DC 93 106
2. J.S. Raglin Anxiolytic effects of physical activity W.P. Morgan, Physical Activity & Mental Health 1997 Taylor & Francis Washington, DC 107 126
3. P. Salmon Effects of physical exercise on anxiety, depression, and sensitivity to stress: A unifying theory Clin Psychol Rev 21 2001 33 61
4. World Health Organization Annual Global Move for Health Initiative: A Concept Paper 2003 World Health Organization Geneva 1-13
5. Institut National de la Santé et de la Recherche Médicale Activité physique - contextes et effets sur la santé 2008 INSERM Paris
6. R.K. Dishman, and J. Buckworth Adherence to physical activity W.P. Morgan, Physical Activity & Mental Health 1997 Taylor & Francis Washington, DC 63 80
7. R.A. Wise Dopamine, learning and motivation Nat Rev Neurosci 5 2004 1 12
8. E.J. Nestler Is there a common molecular pathway for addiction? Nat Neurosci 8 2005 1445 1449
9. C. Lüscher, and R.C. Malenka Drug-evoked synaptic plasticity in addiction: From molecular changes to circuit remodeling Neuron 69 2011 650 663
10. C.M. Sherwin Voluntary wheel running: A review and novel interpretation Anim Behav 56 1998 11 27
11. C.M. Novak, P.R. Burghardt, and J.A. Levine The use of a running wheel to measure activity in rodents: Relationship to energy balance, general activity, and reward Neurosci Biobehav Rev 36 2012 1001 1014
12. D.V. Wang, and J.Z. Tsien Conjunctive processing of locomotor signals by the ventral tegmental area neuronal population Plos One 6 2011 e16528
13. D. Piomelli The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 2003 873 884
14. S. Dubreucq, M. Koehl, D.N. Abrous, G. Marsicano, and F. Chaouloff CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis Exp Neurol 224 2010 106 113
15. L.L. Miller, M.J. Picker, K.T. Schmidt, and L.A. Dykstra Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 kncokout and wildtype mice Psychopharmacology 215 2011 455 465
16. F. Chaouloff, S. Dubreucq, L. Bellocchio, and G. Marsicano Endocannabinoids and motor behavior: CB1 receptors also control running activity Physiology 26 2011 76 77
17. T. Ohno-Shosaku, A. Tanimura, Y. Hashimotodani, and M. Kano Endocannabinoids and retrograde modulation of synaptic transmission Neuroscientist 18 2012 119 132
18. G. Marsicano, and B. Lutz Neuromodulatory functions of the endocannabinoid system J Endocrinol Invest 29 2006 27 46
19. P. Pacher, S. Bátkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 2006 389 462
20. A. El Manira, and A. Kyriakatos The role of endocannbinoid signaling in motor control Physiology 25 2010 230 238
21. U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocr Rev 27 2006 73 100
22. R.G. Pertwee Cannabinoid receptors and pain Prog Neurobiol 63 2001 569 611
23. C.J. Hillard, K.M. Weinlander, and K.L. Stuhr Contributions of endocannabinoid signaling to psychiatric disorders in humans: Genetic and biochemical evidence Neuroscience 204 2012 207 229
24. E.L. Gardner, and S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol Dis 5 1998 502 533
25. R. Maldonado, O. Valverde, and F. Berrendero Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 2006 225 232
26. F. Mátyás, G.M. Urbán, M. Watanabe, K. Mackie, A. Zimmer, T.F. Freund, and I. Katona Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area Neuropharmacology 54 2008 95 107
27. C. Kortleven, C. Fasano, D. Thibault, J.C. Lacaille, and L.E. Trudeau The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice Eur J Neurosci 33 2011 1751 1760
28. B. Szabo, S. Siemes, and I. Wallmichrath Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids Eur J Neurosci 15 2002 2057 2061
29. M. Melis, M. Pistis, S. Perra, A.L. Muntoni, G. Pillolla, and G.L. Gessa Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors J Neurosci 24 2004 53 62
30. C.R. Lupica, and A.C. Riegel Endocannabinoid release from midbrain dopamine neurons: A potential substrate for cannabinoid receptor antagonist treatment of addiction Neuropharmacology 48 2005 1105 1116
31. E.B. Oleson, M.V. Beckert, J.T. Morra, C.S. Lansink, R. Cachope, and R.A. Abdullah Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum Neuron 73 2012 360 373
32. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, and A. Cannich CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
33. K. Monory, F. Massa, M. Egertová, M. Eder, H. Blaudzun, and R. Westenbroek The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron 51 2006 455 466
34. 9-tetrahydrocannabinol in mice PLoS-Biol 5 2007 e269
35. L. Bellocchio, P. Lafenêtre, A. Cannich, D. Cota, N. Puente, and P. Grandes Bimodal control of stimulated food intake by the endocannabinoid system Nat Neurosci 13 2010 281 283
36. S. Dubreucq, I. Matias, P. Cardinal, M. Häring, B. Lutz, M. Marsicano, and F. Chaouloff Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice Neuropsychopharmacology 37 2012 1885 1900
37. 1 receptor modulation of hippocampal LTD Cell 148 2012 1039 1050
38. T. Stühmer, L. Puelles, M. Ekker, and J.L.R. Rubenstein Expression of a Dlx gene enhancer marks adult mouse cortical GABAergic neurons Cereb Cortex 12 2002 75 85
39. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates, 3rd edition 2008 Academic Press New York
40. F. Georges, and G. Aston-Jones Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: A novel excitatory amino acid input to midbrain dopamine neurons J Neurosci 22 2002 5173 5187
41. M. Jalabert, R. Bourdy, J. Courtin, P. Veinante, O.J. Manzoni, M. Barrot, and F. Georges Neuronal circuits underlying acute morphine action on dopamine neurons Proc Natl Acad Sci U S A 108 2011 16446 16450
42. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, and X. Jin Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid cross-talk in vivo Proc Natl Acad Sci USA 106 2009 20270 20275
43. M.M. Holmes, L.A.M. Galea, R.E. Mistlberger, and G. Kempermann Adult hippocampal neurogenesis and voluntary wheel running activity: Circadian and dose-dependent effects J Neurosci Res 76 2004 216 222
44. H. van Praag Exercise and the brain: Something to chew on Trends Neurosci 32 2009 283 290
45. B.K. Keeney, D.A. Raichlen, T.H. Meek, R.S. Wijeratne, K.M. Middleton, G.L. Gerdeman, and T. Garland Jr Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour Behav Pharmacol 19 2008 812 820
46. 2 Pharmacol Rev 62 2010 588 631
47. A. Gardner, and P.E. Mallet Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor silent antagonist. Eur J Pharmacol 530 2006 103 106
48. M. Canals, and G. Milligan Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors J Biol Chem 283 2008 11424 11434
49. 1 receptor antagonist Eur J Pharmacol 651 2011 96 105
50. 2 receptors modulate cocaine's actions in mice Nat Neurosci 14 2011 1160 1166
51. G. Marsicano, and B. Lutz Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 1999 4213 4225
52. M. Navarrete, and A. Araque Endocannabinoids mediate neuron-astrocyte communication Neuron 57 2008 883 893
53. C. Acuna-Goycolea, K. Obrietan, and A.N. van den Pol Cannabinoids excite circadian clock neurons J Neurosci 30 2010 10061 10066
54. A.E. Sanford, E. Castillo, and R.L. Gannon Cannabinoids and hamster circadian activity rhythms Brain Res 1222 2008 141 148
55. B.T. Lett, V.L. Grant, and M.T. Koh Naloxone attenuates the conditioned place preference induced by wheel running in rats Physiol Behav 72 2001 355 358
56. T.W. Belke, and J.P. Wagner The reinforcing property and the rewarding aftereffect of wheel running in rats: a combination of two paradigms Behav Processes 68 2005 165 172
57. B.N. Greenwood, T.E. Foley, T.V. Le, P.V. Strong, A.B. Loughridge, H.E. Day, and M. Fleshner Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway Behav Brain Res 217 2011 354 362
58. E.B. Rasmussen, and C. Hillman Naloxone and rimonabant reduce the reinforcing properties of exercise in rats Exp Clin Psychopharmacol 19 2011 389 400
59. M. Werme, C. Messer, L. Olson, L. Gilden, P. Thoren, E.J. Nestler, and S. Brené ΔFosB regulates wheel running J Neurosci 22 2002 8133 8138
60. S. Geisler, and D.S. Zahm Afferents of the ventral tegmental area in the rat - anatomical substratum for integrative functions J Comp Neurol 490 2005 270 294
61. M. Watabe-Uchida, L. Zhu, S.K. Ogawa, A. Vamanrao, and N. Uchida Whole-brain mapping of direct inputs to midbrain dopamine neurons Neuron 74 2012 858 873
62. B. Chieng, Y. Azriel, S. Mohammadi, and M.J. Christie Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area J Physiol 589 2011 3775 3787
63. C. Fu, B. Cawthon, W. Clinkscales, A. Bruce, P. Winzenburger, and K.C. Ess GABAergic interneuron development and function is modulated by the Tsc1 gene Cereb Cortex 22 2012 2111 2119
64. T. Stühmer, S.A. Anderson, M. Ekker, and J.L.R. Rubenstein Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression Development 129 2002 245 252
65. B.K. Keeney, T.H. Meek, K.M. Middleton, L.F. Holness, and T. Garland Jr Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior Pharmacol Biochem Behav 101 2012 528 537